GLP-1
Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients
Team Metabolic Health The cardiovascular benefits of Ozempic and Wegovy have been unveiled in the SUSTAIN 6 trial and the…
Ozempic can even cut the risk of Alzheimer’s disease, study says
Team Metabolic Health A new study found that semaglutide, the active ingredient in Ozempic and Wegovy, lowered the risk of…
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
Team Metabolic Health Eli Lilly (LLY.N), opens new tab and Hong Kong-listed Laekna (2105.HK), opens new tab will collaborate to develop an experimental obesity…
A Recipe for Better Obesity Care: Integrating GLP-1s with Food as Medicine
Team Metabolic Health Nutrition isn’t a supplement — it’s foundational to metabolic health. It’s time we integrate more ‘Food as…
How GLP-1 went from being a hard-to-handle hormone to a blockbuster success
Team Metabolic Health Lotte Bjerre Knudsen, chief scientific advisor in research and early development at Novo Nordisk, discusses the past…
How GLP-1 Medications like Ozempic are Revolutionizing Weight Loss
Team metabolic Health Whether you’ve seen commercials or read about them in the news, chances are you’ve probably heard of…
A Nutritionist’s Take On Smoothie King’s New GLP-1 Smoothies
Team Metabolic Health The retail food chain recently launched a new smoothie lineup for people taking GLP-1 weight loss drugs…
GLP-1 drugs like Ozempic may protect brain health, several studies show
Team Metabolic Health GLP-1 drugs such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) may offer benefits that extend beyond…
Weight-Loss Surgeries Drop 25 Percent As Americans Opt For GLP-1 Medications
Team Metabolic Health A study shows a 25.6 per cent decline in weight-loss surgeries as more Americans turn to GLP-1…